Arimidex (anastrozole) is now approved as FIRST-LINE therapy of advanced or metastatic breast cancer

Arimidex (anastrozole) is now approved as FIRST-LINE therapy of advanced or metastatic breast cancer.

Until now, Arimidex was approved only as second-line therapy...for when breast cancer progresses despite treatment with tamoxifen.

But recent studies show that Arimidex works at least as well as tamoxifen. It may even halt tumor growth longer than tamoxifen.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote